21. December 2023
A Wenger Plattner team led by Oliver Künzler, Partner, Head Corporate/M&A, advises Blue Water Biotech Inc., NASDAQ: BWV, on all Swiss legal matters related to the acquisition of all shares of Proteomedix AG, a private, commercial-stage oncology diagnostics company. The combined company will now operate under the name Onconetix, Inc.
By acquiring all shares of Proteomedix, its shareholders receive an initial 19.9% stake in Onconetix, Inc.
The further team consisted of Damian Schai, Partner, IP, Benjamin Dürig, Counsel, Corporate/M&A, Martina Braun, Counsel, Commercial/IP/Data Protection, Cristina Solo de Zaldívar, Counsel, Employment, Valérie Berger, Associate, Corporate/M&A, André S. Berne, Associate, Commercial/Competition, Michèle Fierz, Junior Associate, Corporate/M&A.
More Information
Stay up to date and subscribe to our Newsletter.